| Verified against primary record | |
| The warrant for non-randomised designs | Interventions that cannot be randomized, or are extremely unlikely to be studied in randomized trials[1] |
|---|---|
| The trade-off it carries | Undesirable uncertainty for unacceptable error[1] |
| Records read | Methodological guidance, a WHO journal paper and three reviews, 9 October 2026 |
| Independently reported | |
| Definitional problem | Variations in the definition of medical travellers and a lack of agreed methods for data collection[2] |
| Comparative evidence | No studies comparing the health of people who travel abroad for elective surgery were identified[3] |
| Bands apply only to the rows beneath them. The claim that randomised trials are infeasible here is this entry’s reasoning, not a sourced statement. | |
Medical tourism research methods are constrained by three things at once: no agreed definition of the population, no routine dataset that identifies it, and no ethical or practical route to randomising the exposure. What remains is a narrow set of observational designs, and most published work sits at the weakest end of it.
Why the strongest design is unavailable
A randomised trial would allocate patients to be treated at home or abroad. Nobody has done this, and the reason is not oversight: the exposure is a patient’s own funded decision, and allocating it would require withholding or imposing international travel for surgery.
No source read for this entry states that such a trial is impossible, and that step is this site’s reasoning rather than a sourced claim. What is sourced is the general warrant for observational work. Methodological guidance on including non-randomised studies in reviews lists among its reasons interventions that cannot be randomized, or which are extremely unlikely to be studied in randomized trials, and interventions that cannot be adequately studied in randomized trials, and accepts that a review question may not be answerable by a review of randomized trials alone.[1]
The same guidance attaches a warning that belongs with every observational finding in this field: supplementing randomised evidence with non-randomised studies trades undesirable uncertainty for unacceptable error, and justifying inclusion on the grounds that an observed effect was large is a result-driven or post hoc justification.[1] It is cited here from an archived edition and labelled as such.
The designs actually in use, weakest first
Case reports and case series dominate, and are treated in case studies in medical tourism research. Cross-sectional surveys come next, and their sampling frames decide what they can support, as set out in medical tourism surveys. Qualitative interview studies are the main source of evidence on why people travel. Administrative data analysis is rare because the records carry no field identifying treatment abroad.
The balance is visible in the best recent review. A 2026 systematic review of decision-making included 25 studies across 23 distinct samples, of which 12 were qualitative, and records that due to its scant availability, quantitative data was mainly used to supplement and validate the qualitative findings.[4] A 2024 critical review mapped 131 studies published in indexed journals between 1987 and 2022 and found that a comprehensive and systematic review of medical tourism research is lacking.[5]
A paper that discloses its own method honestly
The most useful methodological statement in this literature is a single sentence in which authors describe their own work: we carried out a non-systematic literature review.[2] It appears in a paper published in the World Health Organization’s bulletin, and that candour is why the paper is quotable on the state of the evidence.
Its findings on method are the standing diagnosis of the field. Most of the available data on medical travel is of poor quality. Current data on outcomes are insufficient and rarely generated using rigorous methods. There are variations in the definition of medical travellers and a lack of agreed methods for data collection. Sources are often not accessible or do not explain how estimated figures were calculated. And it is difficult to find representative samples of patients who travel for care.[2]
That paper is from 2015 and its wording should be dated when quoted. The 2026 reviews are better conducted and reach a compatible conclusion about the quantitative base, so the diagnosis has held even as method has improved.
What reviewers say should be done instead
Reviewers in this field have been specific about feasible designs, which makes their recommendations more useful than a general call for better evidence. A prospective registry of cases may assist in quantifying the problem for both primary and secondary care. There is a need for a systematic approach to collecting data, producing robust and reliable data about who is travelling abroad for elective surgery and where they are travelling to. Future studies should collect and report full demographic details including gender, ethnicity and socioeconomic status. And severity should be reported using a recognised complication classification so that studies can be compared.[3]
The same reviewers summarise the position bluntly: we still do not know how many people go abroad for elective surgery or how many people subsequently have complications. They also record that they identified no studies investigating benefits, and no evidence comparing the short or long-term health of people who travel abroad for elective surgery.[3] Both are statements about what their search retrieved.
A 2026 review adds the complementary recommendation that prospective studies with generalisable samples are needed, particularly for bariatric tourism.[4]
A framework for what the evidence would have to cover
The bulletin paper proposes three domains for research in this field, naming quality standards, informed decision-making, and economic and legal protection, and argues that effective research on medical travel as a global phenomenon requires consideration of all three.[2] That structure is useful because it separates questions that are commonly run together: whether the care was good, whether the patient could judge it beforehand, and whether anything could be done afterwards if it was not.
See also
- Systematic reviews of medical tourism, what the reviews found and how narrow each is
- Case studies in medical tourism research, the dominant design
- Selection bias in medical tourism research, the constraint on every observational design here
- Clinical outcomes in medical tourism, the question the methods cannot currently reach
References
- Cochrane. Cochrane Handbook for Systematic Reviews of Interventions, archived version 5.1, chapter 13, section 13.1.2, why consider non-randomized studies. Verified against primary record: section opened and read; superseded by later editions. Retrieved 9 October 2026.
- Ruggeri K, Zalis L, Meurice CR, Hilton I, Ly TL, Zupan Z, Hinrichs S. Evidence on global medical travel. Bulletin of the World Health Organization, 2015;93:785-789. Independently reported: peer-reviewed paper in a World Health Organization journal, read in full including its own method statement. Retrieved 9 October 2026.
- England C, Bromham N, Needham-Taylor A, Hounsome J, Gillen E, Ingram BJ, Davies J, Edwards A, Lewis R. Complications and costs to the UK National Health Service due to outward medical tourism for elective surgery, a rapid review. BMJ Open, 2026;16(1):e109050, published 13 January 2026; preprint at medRxiv 10.1101/2025.04.02.25325086. Independently reported: publicly commissioned review, preprint full text read. Retrieved 9 October 2026.
- Nichol B, Ray D, Tanner L, Oliver EJ, Vlaev I, Sniehotta F, McGowan L. Decision-making about bariatric and cosmetic medical tourism from countries with universal healthcare, a rapid systematic review. Globalization and Health, 2026;22:45. Independently reported: peer-reviewed systematic review. Retrieved 9 October 2026.
- Wong AKF, Vongvisitsin TB, Li P, Pan Y, Ryan C. Revisiting medical tourism research, critical reviews and implications for destination management and marketing. Journal of Destination Marketing and Management, 2024;33:100924. Independently reported: repository record carrying the publisher abstract. Retrieved 9 October 2026.
Sourcing note: the methodological guidance, the bulletin paper and the three reviews were opened and read on 9 October 2026, one of them at repository-record level as marked. The guidance is an archived edition and is labelled so. No source states that randomised trials are impossible in this field; that inference is this entry’s own and is presented as reasoning. The statements that no comparative or benefit studies were identified are the reviewers’ accounts of their own searches, not proof that none exist.